Literature DB >> 23456425

CD73+ adipose-derived mesenchymal stem cells possess higher potential to differentiate into cardiomyocytes in vitro.

Qiong Li1, Li-Jie Qi, Zhi-Kun Guo, He Li, Hong-Bo Zuo, Na-Na Li.   

Abstract

Adipose-derived mesenchymal stem cells (ADMSCs) are an attractive adult-derived stem cell population for cardiovascular repair. ADMSCs are heterogeneous cell populations with pluripotent capacity to differentiate into different types of cells. In the present study, we investigated the biological characteristics and differentiation potential of CD73-positive (CD73(+)) and CD73-negative (CD73(-)) ADMSCs. Our results show that in terms of morphological shape, CD73(+)-ADMSCs are mainly small-sized cells, whereas CD73(-)-ADMSCs are big-sized cells; both subpopulations can equally differentiate into adipocytes and osteoblasts in vitro. However, the CD73(+)-ADMSCs possess a higher potential to differentiate into cardiomyocytes than the CD73(-)-ADMSCs. The expression of the cardiac-specific genes, cTnT, Gata4, and Nkx2.5, is much higher in the CD73(+)-ADMSCs than in the CD73(-)-ADMSCs. Furthermore, Nanog expression at both the mRNA and protein levels is significantly higher in CD73(+)-ADMSCs than in CD73(-)-ADMSCs, suggesting that CD73(+)-ADMSCs are an undifferentiated subpopulation that can differentiate into cardiomyocytes in vitro more efficiently. Therefore, this study facilitates a better understanding of the differentiation of the ADMSCs subgroups and attempts to identify if CD73 is a useful marker for sorting and purifying the subpopulation of ADMSCs with a higher capacity for differentiation into cardiomyocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23456425     DOI: 10.1007/s10735-013-9492-9

Source DB:  PubMed          Journal:  J Mol Histol        ISSN: 1567-2379            Impact factor:   2.611


  42 in total

1.  Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma.

Authors:  Jason R Smith; Radhika Pochampally; Anthony Perry; Shu-Ching Hsu; Darwin J Prockop
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

2.  Differentiation potential of human mesenchymal stem cells derived from adipose tissue and bone marrow to sinus node-like cells.

Authors:  Jing Yang; Tao Song; Pan Wu; Yongjun Chen; Xinrong Fan; Hui Chen; Jun Zhang; Congxin Huang
Journal:  Mol Med Rep       Date:  2011-10-03       Impact factor: 2.952

3.  Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes.

Authors:  Hiroko Tsuji; Shunichiro Miyoshi; Yukinori Ikegami; Naoko Hida; Hironori Asada; Ikuko Togashi; Junshi Suzuki; Masaki Satake; Hikaru Nakamizo; Mamoru Tanaka; Taisuke Mori; Kaoru Segawa; Nobuhiro Nishiyama; Junko Inoue; Hatsune Makino; Kenji Miyado; Satoshi Ogawa; Yasunori Yoshimura; Akihiro Umezawa
Journal:  Circ Res       Date:  2010-05-28       Impact factor: 17.367

4.  Specific plasma membrane protein phenotype of culture-amplified and native human bone marrow mesenchymal stem cells.

Authors:  Bruno Delorme; Jochen Ringe; Nathalie Gallay; Yves Le Vern; Dominique Kerboeuf; Christian Jorgensen; Philippe Rosset; Luc Sensebé; Pierre Layrolle; Thomas Häupl; Pierre Charbord
Journal:  Blood       Date:  2007-12-17       Impact factor: 22.113

Review 5.  Phenotypes of stem cells from diverse origin.

Authors:  Attila Tárnok; Henning Ulrich; Jozsef Bocsi
Journal:  Cytometry A       Date:  2010-01       Impact factor: 4.355

6.  Isolation, identification and multipotential differentiation of mouse adipose tissue-derived stem cells.

Authors:  Masoumeh Fakhr Taha; Vahideh Hedayati
Journal:  Tissue Cell       Date:  2010-05-21       Impact factor: 2.466

7.  Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes.

Authors:  Sunil Rangappa; Chen Fen; Eng Hin Lee; Ariff Bongso; Eugene Kwang Wei Sim; Eugene Kwang Sim Wei
Journal:  Ann Thorac Surg       Date:  2003-03       Impact factor: 4.330

8.  Bone marrow cells adopt the cardiomyogenic fate in vivo.

Authors:  Marcello Rota; Jan Kajstura; Toru Hosoda; Claudia Bearzi; Serena Vitale; Grazia Esposito; Grazia Iaffaldano; M Elena Padin-Iruegas; Arantxa Gonzalez; Roberto Rizzi; Narissa Small; John Muraski; Roberto Alvarez; Xiongwen Chen; Konrad Urbanek; Roberto Bolli; Steven R Houser; Annarosa Leri; Mark A Sussman; Piero Anversa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-26       Impact factor: 11.205

9.  5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.

Authors:  E Martin-Rendon; D Sweeney; F Lu; J Girdlestone; C Navarrete; S M Watt
Journal:  Vox Sang       Date:  2008-06-28       Impact factor: 2.144

10.  Nanog is the gateway to the pluripotent ground state.

Authors:  Jose Silva; Jennifer Nichols; Thorold W Theunissen; Ge Guo; Anouk L van Oosten; Ornella Barrandon; Jason Wray; Shinya Yamanaka; Ian Chambers; Austin Smith
Journal:  Cell       Date:  2009-08-21       Impact factor: 41.582

View more
  12 in total

1.  CD73+ Mesenchymal Stem Cells Ameliorate Myocardial Infarction by Promoting Angiogenesis.

Authors:  Qiong Li; Huifang Hou; Meng Li; Xia Yu; Hongbo Zuo; Jianhui Gao; Min Zhang; Zongjin Li; Zhikun Guo
Journal:  Front Cell Dev Biol       Date:  2021-05-12

Review 2.  The dynamic facets of the cardiac stroma: from classical markers to omics and translational perspectives.

Authors:  Vittorio Picchio; Antonella Bordin; Erica Floris; Claudia Cozzolino; Xhulio Dhori; Mariangela Peruzzi; Giacomo Frati; Elena De Falco; Francesca Pagano; Isotta Chimenti
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

3.  Expression of interleukin-12 by adipose-derived mesenchymal stem cells for treatment of lung adenocarcinoma.

Authors:  Xin Li; Peng Zhang; Xiaozhi Liu; Peng Lv
Journal:  Thorac Cancer       Date:  2015-01-07       Impact factor: 3.500

4.  Phenotypic and immunomodulatory properties of equine cord blood-derived mesenchymal stromal cells.

Authors:  Laurence Tessier; Dorothee Bienzle; Lynn B Williams; Thomas G Koch
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

5.  Allogeneic guinea pig mesenchymal stem cells ameliorate neurological changes in experimental colitis.

Authors:  Rhian Stavely; Ainsley M Robinson; Sarah Miller; Richard Boyd; Samy Sakkal; Kulmira Nurgali
Journal:  Stem Cell Res Ther       Date:  2015-12-30       Impact factor: 6.832

Review 6.  Adipose-derived stem cells: selecting for translational success.

Authors:  Kavan S Johal; Vivien C Lees; Adam J Reid
Journal:  Regen Med       Date:  2015       Impact factor: 3.806

7.  Anti-DKK1 Enhances the Early Osteogenic Differentiation of Human Adipose-Derived Stem/Stromal Cells.

Authors:  Yiyun Wang; Stefano Negri; Zhao Li; Jiajia Xu; Ching-Yun Hsu; Bruno Peault; Kristen Broderick; Aaron W James
Journal:  Stem Cells Dev       Date:  2020-06-22       Impact factor: 3.272

8.  Aldehyde dehydrogenase activity helps identify a subpopulation of murine adipose-derived stem cells with enhanced adipogenic and osteogenic differentiation potential.

Authors:  Harumichi Itoh; Shimpei Nishikawa; Tomoya Haraguchi; Yu Arikawa; Shotaro Eto; Masato Hiyama; Toshie Iseri; Yoshiki Itoh; Munekazu Nakaichi; Yusuke Sakai; Kenji Tani; Yasuho Taura; Kazuhito Itamoto
Journal:  World J Stem Cells       Date:  2017-10-26       Impact factor: 5.326

9.  Effect of donor age on the proliferation and multipotency of canine adipose-derived mesenchymal stem cells.

Authors:  Jienny Lee; Keum Sil Lee; Chan-Lan Kim; Jeong Su Byeon; Na-Yeon Gu; In-Soo Cho; Sang-Ho Cha
Journal:  J Vet Sci       Date:  2017-06-30       Impact factor: 1.672

10.  Cystine transporter expression is a marker to identify a subpopulation of canine adipose-derived stem cells.

Authors:  Harumichi Itoh; Shimpei Nishikawa; Kenji Tani; Hiroshi Sunahara; Munekazu Nakaichi; Toshie Iseri; Yasuho Taura; Kazuhito Itamoto
Journal:  J Vet Med Sci       Date:  2020-04-09       Impact factor: 1.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.